Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epratuzumab Extension Study in Japanese SLE Patients
NCT01534403Phase 2Completed
- Sponsor
- UCB
- Start
- Jan 2012
- Primary completion
- Feb 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of epratuzumab in systemic lupus erythematosus (SLE), sponsored by UCB. Started Jan 2012; status: completed.
02
Drugs
epratuzumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01534403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01534403.